BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Nov 21, 2026; 32(43): 120562
Published online Nov 21, 2026. doi: 10.3748/wjg.120562
Table 1 Characteristics of the included patients, n (%)/mean ± SD

Training set
P valueInternal validation set (n = 72)P valueExternal validation set (n = 61)P value
Total (n = 168)
ER (n = 67)
Non-ER (n = 101)
Patient characteristic
Age (years)56.54 ± 9.5656.15 ± 9.7356.79 ± 9.480.67156.28 ± 8.730.8454.95 ± 9.340.266
Sex0.8740.2150.173
Male123 (73.2)48 (71.6)75 (74.3)47 (65.3)50 (65.3)
Female45 (26.8)19 (28.4)26 (25.7)25 (34.7)11 (34.7)
Etiology0.1470.9150.934
HBV155 (92.3)64 (95.5)91 (90.1)67 (93.1)57 (93.4)
HCV9 (5.4)3 (4.5)6 (5.9)3 (4.2)3 (4.9)
Others4 (2.4)0 (0.0)4 (4.0)2 (2.8)1 (1.6)
Tumor characteristics
Tumor size (cm)2.39 ± 0.912.72 ± 0.912.18 ± 0.91< 0.0012.33 ± 0.810.6512.46 ± 0.970.612
No. of tumors< 0.0010.7050.516
Solitary123 (73.2)39 (58.2)84 (83.2)51 (70.8)42 (68.9)
Multiple45 (26.8)28 (41.8)17 (16.8)21 (29.2)19 (31.1)
Barcelona Clinic Liver Cancer stage< 0.0010.7020.862
046 (27.4)5 (7.5)41 (40.6)18 (25.0)16 (26.2)
A122 (72.6)62 (92.5)60 (59.4)54 (75.0)45 (73.8)
Laboratory index
AST, IU/L36.86 ± 5.2537.00 ± 5.3836.76 ± 5.190.77936.25 ± 5.220.40835.19 ± 5.410.036
ALT, IU/L31.01 ± 21.7834.42 ± 23.9628.76 ± 20.010.09933.12 ± 25.710.51728.23 ± 15.930.362
TBIL, μmol/L24.59 ± 13.6525.63 ± 14.8023.89 ± 12.870.42321.34 ± 11.740.0821.44 ± 12.960.12
ALB, g/L30.78 ± 12.6631.36 ± 10.0830.40 ± 14.140.63433.43 ± 20.900.22932.74 ± 10.530.28
r-GGT (U/L)35.78 ± 26.6838.60 ± 31.9233.91 ± 22.520.26632.01 ± 18.890.27840.42 ± 29.960.261
PLT, × 109/L110.54 ± 55.67106.62 ± 51.70113.14 ± 58.140.459112.81 ± 56.080.774104.41 ± 54.450.459
Child-Pugh grade0.2490.9750.204
A121 (72.0)47 (70.1)74 (73.3)52 (72.2)49 (80.3)
B47 (29.0)20 (29.9)27 (26.7)20 (27.8)12 (19.7)
AFP, ng/mL215.98 ± 351.69329.83 ± 440.58140.44 ± 252.970.001187.27 ± 331.250.556294.55 ± 378.510.144


Write to the Help Desk